Delivery Order SPE2DB22D3501-SPE2DB25FWU42
- Not listed
- The Defense Logistics Agency awarded a $3,943.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 20 mg, with an ultimate completion date of August 18, 2025. This non-set-aside contract represents a pharmaceutical supply delivery executed through the company's established federal procurement relationship. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,491.10 to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 30 mg, with performance completion targeted for September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency has awarded a delivery order valued at $1,610.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $17,044.69 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (90-count units) under a firm fixed price contract type. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $1,111.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count). This delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $1,141.26. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,968.50 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, with no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be performed and delivered from the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,372.16 to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 40 mg. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 18, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.66 to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units). The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This award was made through open competition with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,760.99 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-count). The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWU42Delivery Order
The Defense Logistics Agency awarded a $1,354.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 40 mg, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements through open competition, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/8/25 |